Clinical Trials Directory

Trials / Completed

CompletedNCT01402570

Glutathione and Health With Post-Polio Syndrome

Oral Glutathione and Health Outcomes Among Persons With Post-Polio Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
50 Years – 65 Years
Healthy volunteers
Not accepted

Summary

In this study, people who have symptoms of post polio will take oral glutathione supplements for three months. Their levels of fatigue, physical activity and sleep efficiency will be assessed.

Detailed description

Subjects will take a glutathione supplement by mouth for three months after an initial medical visit, blood draw and physical exam. There are four timepoints during the three months when subjects will fill out surveys and record food intake and sleep times in diaries for seven days. They will also wear a small device for seven days, a Sensewear monitor that records physical activity, body temperature and other measures. After the fourth timepoint they will return to the medical center for another physical exam and blood draw. Physicians trained in physical medicine and rehabilitation will be monitoring the study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGlutathioneglutathione is a dietary supplement and an antioxidant. Subjects will take 1000 mg per day for three month. Each capsule contains 500 mg glutathione.

Timeline

Start date
2011-08-01
Primary completion
2013-04-01
Completion
2013-07-01
First posted
2011-07-26
Last updated
2017-02-17
Results posted
2017-02-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01402570. Inclusion in this directory is not an endorsement.